ProCAncer-I in the 44th International Engineering in Medicine and Biology Conference in Glasgow

Published on: July 5, 2022
Categories: News
We are looking forward to participating in the 44th IEEE International Engineering in Medicine and Biology Conference in Glasgow! The Initiative will organize a miniSymposium under the session on Biomedical Imaging and Image Processing, with the title: Trustworthy AI in Cancer Imaging Research! 

Cancer research has been central in the biomedical community, seeking earlier and safer cancer diagnosis and prognosis, as well as better and more personalized treatment decisions. AI is increasingly receiving attention as a major component leveraging cancer imaging and multi-omics data analysis, towards these goals.

A key factor to ensure the success and impact of AI in cancer research and secure the wider adoption in clinical practice is the aspect of trustworthiness. This entails a multifaceted strategy in all phases of an AI service development, spanning from AI design to training and validation and including –among others– human oversight, technical robustness, data governance, transparency, fairness, and auditability. AI trustworthiness is currently moving from the definition of its theoretical framework capturing all trustworthiness perspectives to guidelines and best practices for its practical implementation. It is also evolving to incorporate the particularities of the cancer research areas and the needs of the w hole user spectrum. Incorporating explainability/interpretability in AI is an emerging field that is receiving lately much attention, while XAI validation is still an open issue that also involves several human aspects. As regards the much-discussed AI fairness, recent initiatives attempt to generate a framework based on best practices. Keeping in mind these multiple and diverse challenges and opportunities in the field of cancer research, the aim of this mini-symposium is to address the important questions: “How to design AI that is trustworthy”, and “How to validate AI trustworthiness” in the scope of AI for cancer imaging.

Speaker will be:

Ioanna Chouvarda, Aristotle University of Thessaloniki, Greece Karim Lekadir, University of Barcelona, Spain
Fuensanta Bellvis Bataller, Quibim, Spain Sara Colantonio, CNR, Italy
Haridimos Kondylakis, ICS-FORTH, Greece
Alexandra Kosvyra, Aristotle University of Thessaloniki, Greece
João Santinha, Champalimaud Foundation, Portugal

For more information about the Conference: https://embc.embs.org/2022

Highlights

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and  ii) include...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I will be organising the 3rd Dissemination Event at the 21st IEEE International Symposium on Biomedical Imaging, which will be held in Athens, Greece, May 27-30, 2024. ProCAncer-I will organise the Workshop “Integrating imaging Data and AI models for...

ProCAncer-I at the ECR 2024 in Vienna

ProCAncer-I at the ECR 2024 in Vienna

A great congress once more! Artificial Intelligence (AI) took the spotlight at the European Radiology Congress (ECR) held at the Austria Center Vienna from February 28 to March 3. Under the theme of 'Next Generation Radiology,' cutting-edge technologies were...

Stay in touch!